M., Furberg, J
Who Should Consider a GLP-1 Subscription Model, and Who Should Pause GLP-1 subscriptions work best for patients with stable insurance coverage, predictable monthly budgets, and clear clinical indication (type 2 diabetes or weight management under provider guidance)
Regulators are aware of the scale of patient exposure and the clinical sensitivity of these therapies
"Drug Approval Package: Vyleesi"
[169] [170] According to a Cochrane review on withdrawal in individuals who compulsively use amphetamine and methamphetamine, "when chronic heavy users abruptly discontinue amphetamine use, many report a time-limited withdrawal syndrome that occurs within 24 hours of their last dose." [171] This review noted that withdrawal symptoms in chronic, high-dose users are frequent, occurring in roughly 88% of cases, and persist for 34 weeks with a marked "crash" phase occurring during the first week
Mucoadhesive hydrophilic polymers, such as POLYOX polyethylene oxide, are other polymeric excipients that are investigated in buccal delivery systems, such as tablets and oral films